Market Place
Sourcing Support
Blue Shield of California Slashes Cost of World`s Best-selling Drug
01 Oct 2024 //
PR NEWSWIRE
Fresenius Kabi And AABB Announce 19th Annual Blood Collectors Week Sept 1-7
01 Sep 2024 //
BUSINESSWIRE
Fresenius Kabi Expands Women`s Health Portfolio With Generic Option
27 Aug 2024 //
BUSINESSWIRE
Fresenius Kabi Wins Premier Inc.`s 2024 Trailblazer Award
05 Aug 2024 //
BUSINESSWIRE
Arunesh Verma Joins Fresenius Kabi USA as President
10 Jul 2024 //
BUSINESSWIRE
Fresenius Launches Subcutaneous Tyenne In US Market
02 Jul 2024 //
BUSINESSWIRE
MAbxience Names New Chief Executive Officer
10 May 2024 //
CONTRACT PHARMA
Fresenius Momentum In (Bio)Pharma, Launches Tyenne® Biosimilar
15 Apr 2024 //
BUSINESSWIRE
Kabi’s Manufacturing Site in Norway taken over by Prange and Adragos
01 Mar 2024 //
PRESS RELEASE
Fresenius Kabi Further Expands Oncology Portfolio
28 Feb 2024 //
BUSINESSWIRE
Healthcare group Fresenius tops Q4 operating profit forecast
20 Feb 2024 //
REUTERS
Fresenius Launches Posaconazole Injection for Treatment of Fungal Infections
29 Jan 2024 //
BUSINESSWIRE
Fresenius Kabi and Mayo Clinic Enter into Agreement for Ivenix® Infusion System
14 Dec 2023 //
BUSINESSWIRE
Prange And Adragos Acquire Fresenius Kabi`s Norway Manufacturing Site
15 Nov 2023 //
PRESS RELEASE
Fresenius Kabi`s Biologic Idacio (adalimumab) Receives Approval in the U.S.
31 Oct 2023 //
FDA
Fresenius Celebrates 25th Anniversary of National Blood Donation Hall of Fame
10 Oct 2023 //
BUSINESSWIRE
Fresenius Kabi Introduces Smart Labels for Diprivan
09 Oct 2023 //
BUSINESSWIRE
Fresenius Kabi Named 2023 Supplier Partner of the Year by Vizient
03 Oct 2023 //
BUSINESSWIRE
Fresenius Kabi Selected for Year to Exhibit the Ivenix Infusion System
02 Oct 2023 //
BUSINESSWIRE
FDA turns to Fresenius imports from EU to help with common cancer drug shortage
28 Sep 2023 //
ENDPTS
Tyenne, Fresenius Kabi’s tocilizumab biosimilar, receives EC approval
20 Sep 2023 //
PRESS RELEASE
Virginia Associates Chooses the Ivenix Infusion System from Fresenius Kabi
14 Sep 2023 //
BUSINESSWIRE
Fresenius Kabi and AABB Announce Start of 18th Annual Blood Collectors Week
03 Sep 2023 //
BUSINESSWIRE
Fresenius Kabi Launches Plerixafor Injection
09 Aug 2023 //
BUSINESSWIRE
Fresenius Kabi Expands Radiology Portfolio with Launch of Gadobutrol Injection
08 Aug 2023 //
BUSINESSWIRE
J&J`s Stelara settlement streak rolls on with Fresenius Kabi, Formycon deal
08 Aug 2023 //
FIERCE PHARMA
Shares in Pfizer rivals Hikma, Fresenius rally after tornado hits factory
20 Jul 2023 //
REUTERS
Fresenius` Generic Sodium Chloride Receives Approval in the U.S.
11 Jul 2023 //
FDA
Fresenius Kabi Introduces New Presentation for Fentanyl Citrate Injection
11 Jul 2023 //
BUSINESSWIRE
Expanding Access to Women’s Health Fresenius Kabi Launches Fertility Treatment
10 Jul 2023 //
BUSINESSWIRE
Fresenius launches biosimilar version of AbbVie`s Humira at 5% discount
04 Jul 2023 //
REUTERS
Fresenius Kabi Broadens Radiology Portfolio with its Market Authorized Generic
21 Jun 2023 //
BUSINESSWIRE
Fresenius Kabi Launches Vasopressin Injection
14 Jun 2023 //
BUSINESSWIRE
Fresenius Kabi Expands Ready-to-Administer Portfolio with Diazepam Injection
31 May 2023 //
BUSINESSWIRE
Fresenius Kabi Launches RFID-Enabled Rocuronium Bromide Injection
30 May 2023 //
BUSINESSWIRE
CMS grants Fresenius Kabi permanent, product-specific Q-Code for Stimufend®
16 May 2023 //
BUSINESSWIRE
Stimufend® (pegfilgrastim-fpgk) Now Available in the United States
16 Feb 2023 //
BUSINESSWIRE
Fresenius` Generic Ketamine Hydrochloride Receives Approval in the U.S.
13 Jan 2023 //
FDA
Fresenius Kabi’s Ivenix Infusion System Goes Live at San Luis Valley Health
10 Jan 2023 //
BUSINESSWIRE
Fresenius` Generic Zinc Sulfate Monohydrate Receives Approval in the U.S.
27 Dec 2022 //
FDA
Fresenius Targets Treatment of Seizures with Generic Lacosamide Injection
15 Dec 2022 //
BUSINESSWIRE
Fresenius nabs the latest Humira biosimilar approval
15 Dec 2022 //
ENDPTS
Fresenius` Biologic Idacio ( Adalimumab) Receives Approval in the U.S.
13 Dec 2022 //
FDA
Fresenius Kabi Introduces Pralatrexate Injection for the Treatment of Lymphoma
08 Dec 2022 //
BUSINESSWIRE
Ferinject approved in China for the treatment of iron deficiency in patients
28 Nov 2022 //
PHARMTECH
Ferinject approved in Chinafor the treatment of iron deficiency in patients
28 Nov 2022 //
BUSINESSWIRE
Fresenius`s Generic Diazepam Receives Approval in the U.S.
09 Nov 2022 //
FDA
Fresenius` new CEO signals `reset` as activist investor circles
31 Oct 2022 //
FIERCEPHARMA
Fort Goes Live with Smart Pump Interoperability with Ivenix Infusion System
11 Oct 2022 //
BUSINESSWIRE
Fresenius Kabi Named 2022 Pharmaceutical Supplier Partner of the Year by Vizient
06 Oct 2022 //
BUSINESSWIRE
Fresenius Kabi Launches Gadoterate Meglumine Injection, USP
04 Oct 2022 //
BUSINESSWIRE
ScaleReady Introduces the Cue® Cell Processing System From Fresenius Kabi
03 Oct 2022 //
BUSINESSWIRE
Fresenius Kabi receives U.S. FDA approval for biosimilar Stimufend
07 Sep 2022 //
PRESS RELEASE
Fresenius Kabi, Introduces Data Matrix Barcodes on all Drugs
08 Aug 2022 //
BUSINESS WIRE
Fresenius Kabi`s Sugammadex Receives Approval in the EMA
21 Jul 2022 //
EMA
Romidepsin for Injection Available from Fresenius Kabi
12 Jul 2022 //
BUSINESSWIRE
Fagron expands its US sterile compounding footprint with East coast acquisition
05 Jul 2022 //
GLOBENEWSWIRE
Fresenius Kabi Expands RFID Compatibility for Hospital Inventory Management
14 Jun 2022 //
BUSINESSWIRE
Fresenius Kabi Introduces Copay Assistance for Cancer Treatments
13 Apr 2022 //
BUSINESSWIRE
